Nasdaq-listed Tharimmune (THAR) has raised about $540 million in a private placement led by DRW and Liberty City Ventures, as the biotech firm pivots toward a digital asset treasury (DAT) strategy centered on canton coin (CC), the company said in a press release Monday.
THAR is up roughly 30% on the announcement. The thinly-traded canton coin, the utility token powering the Canton Network, a blockchain designed for institutional finance, is lower by 4%.
STORY CONTINUES BELOW
Don’t miss another story.Subscribe to the Crypto Daybook Americas Newsletter today. See all newsletters svg]:max-w-[theme(spacing.8)] transition-transform-colors-opacity motion-reduce:transition-none text-default-foreground data-[hover=true]:opacity-hover w-full md:w-auto bg-new-yellow”>
Trending: Ted Cruz Predicts When the Shutdown Will Likely End
Sign me up
By signing up, you will receive emails about CoinDesk products and you agree to
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!